To perform innovative trial designs with clinically relevant outcomes such as endpoints, biomarkers, and epidemiology data included aspart of every protocol, to obtain comprehensive and comparative…
Ended Awarded Last action
- Contract number
- 75N94019F00125
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,583,491
Award facts
- Opportunity
-
- NIHNICHDOPPTB20182 Solicitation number
- Contract value 100% obligated
- $10,583,491.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $2,111,031 | |
| Other Administrative Action | $0 | |
| Original award | $8,472,460 |
About this award
This is a cost-no-fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Duke University. The $10,583,491.00 contract is for Duke to perform innovative clinical trial designs with relevant outcomes, endpoints, biomarkers, and epidemiology data to advance pediatric medical science. This contract is part of the Best Pharmaceuticals for Children Act - Pediatric Trials Network (BPCA-PTN) program. No set-aside designation was used for this award. Duke University, a private non-profit research university, will serve as the prime contractor for this work, which has a period of performance through July 31, 2025.
Description
To perform innovative trial designs with clinically relevant outcomes such as endpoints, biomarkers, and epidemiology data included aspart of every protocol, to obtain comprehensive and comparative analysis of the data for the advance of science and
Quick answers
Who was awarded contract 75N94019F00125?
75N94019F00125 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on September 12, 2019.
How much is contract 75N94019F00125 worth?
The government has obligated $10,583,491 on 75N94019F00125.
Is contract 75N94019F00125 an order under another contract?
Yes. 75N94019F00125 is a delivery order under 75N94018D00003, an indefinite delivery contract.
Was contract 75N94019F00125 competed?
The extent of competition for 75N94019F00125 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award